ArticleBiomedical engineering online2026
Predictive value of CT target scan-based radiomics and clinical features for patients with chronic obstructive pulmonary disease combined with malignant pulmonary nodules.
Article in Biomedical engineering online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesThis study aims to evaluate the predictive value of CT target scan-based radiomics and clinical features in patients with chronic obstructive pulmonary disease (COPD) who also present with malignant pulmonary nodules.
methodsA retrospective analysis was conducted on 104 patients diagnosed with COPD and pulmonary nodules, treated at our hospital between September 2022 and September 2024. The cohort was stratified into a benign group (n = 48) and a malignant group (n = 66) based on the definitive pathological examination results. All participants underwent spiral CT target scanning. Univariate and multivariate logistic regression analyses were employed to identify influencing factors. In addition, a receiver operating characteristic (ROC) curve was constructed to assess the predictive value.
resultsIn comparison with the benign group, the malignant group exhibited a greater aspect ratio, a higher proportion of patients over 45 years of age, and increased occurrences of mixed ground-glass opacities, calcification, spiculation sign, vascular convergence sign, and lobulation sign, along with a significant elevation in the CAT score (P < 0.05). The CAT score, density, spiculation sign, and lobulation sign emerged as independent risk factors for the presence of malignant pulmonary nodules in patients with COPD (P < 0.05). The aforementioned imaging factors were incorporated into a multivariate logistic regression model: Logit (P) = 10.490 + 0.917 × CAT score + 1.547 × density + 0.823 × spiculation sign + 0.736 × lobulation sign. The area under the curve (AUC) values for the CAT score, radiomics model, and combined model were 0.768, 0.826, and 0.909, respectively.
conclusionsRadiomics features derived from CT target scanning, when combined with clinical features, demonstrate promising potential for differentiating between benign and malignant pulmonary nodules in patients with COPD. This approach may indirectly reflect patients' pulmonary function and serve as a reference for the early diagnosis of COPD combined with lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.